Using real-world outcomes data from the STS/ACC TVT Registry, findings from the EVOQUE study presented at TCT 2025 demonstrate favorable safety and effectiveness of transcatheter tricuspid valve replacement (TTVR) at 30 days using the EVOQUE…
Using real-world outcomes data from the STS/ACC TVT Registry, findings from the EVOQUE study presented at TCT 2025 demonstrate favorable safety and effectiveness of transcatheter tricuspid valve replacement (TTVR) at 30 days using the EVOQUE…